Poster: Absorption and Physiology-Based PK

A whole-body physiologically-based pharmacokinetic Model for ketoconazole in different species ready to be used to predict dynamic drug-drug-interactions

Thursday 16 October, 2025

Objectives: Ketoconazole (KTZ) is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme system. As coadministration of KTZ with…

Read more

Determination of the most influential sources of variability of tacrolimus trough blood levels in adult liver transplant patients: a bottom-up approach

Thursday 16 October, 2025

Objectives: Tacrolimus (TAC), an immusuppressive drug used for the prevention of graft rejection after liver transplantation, presents a large pharmacokinetic…

Read more

Monoclonal Antibody Disposition beyond Target Binding: Impact of FcRn on Clearance and Derivation of Mechanistic Compartment Models

Thursday 16 October, 2025

Objectives: Despite the detailed knowledge of the molecular processes involved in the disposition of monoclonal antibodies (mAbs), the development of…

Read more

Relevance of Endogenous IgG Binding to FcRn in PBPK Models of Therapeutic mAbs

Thursday 16 October, 2025

Objectives: There is a high interest in developing mechanistic pharmacokinetic models to describe the disposition of monoclonal antibodies (mAbs). Physiologically-based…

Read more

Paediatric PBPK drug-disease modelling and simulation towards optimisation of drug therapy: an example of milrinone for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery

Thursday 16 October, 2025

Objectives: There is an undisputable need for improving paediatrics’ access to safe and effective drug therapy. Thus, regulatory agencies have…

Read more

Enterohepatic Recirculation of Free and Conjugated Silybin Following Administration of a Chewing Gum with Milk Thistle Extract

Thursday 16 October, 2025

Objectives: Silybin is the main ingredient of silymarin, a milk thistle extract, with recognised anti-hepatotoxic and free radical scavenging activity….

Read more

Population pharmacokinetics of an experimental drug’s oral modified release formulation in healthy volunteers, quantification of sensitivity to types and timings of meals.

Thursday 16 October, 2025

Objectives: The objective of this analysis was to understand the modified (extended) release formulation PK characteristics of an experimental drug,…

Read more

GastroPlus PBPK/PD Model Applied to Estimating Dose for an Elderly Population in an Alzheimer’s Disease Clinical Trial

Thursday 16 October, 2025

Objectives: Certain neurosteroid metabolites of progesterone are known to be positive allosteric modulators of the GABAa receptor and have application…

Read more

Support in PML for Absorption Time Lag via Transit Compartments

Thursday 16 October, 2025

Objectives: Savic et al [1] give a closed-form computation to model absorptive delay through multiple transit compartments, where the number…

Read more

Computer simulations of bioequivalence trials: drugs with sequential metabolism

Thursday 16 October, 2025

Iintroduction: The analyte (parent drug or metabolite) to be evaluated in bioequivalence trials is still today a controversial issue, with…

Read more